Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies

por Ardini, Elena, Siena, Salvatore
Publicado 2020

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

por Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore
Publicado 2016

Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials

por Koukakis, Reija, Gatta, Francesca, Hechmati, Guy, Siena, Salvatore
Publicado 2016

Exploring the links between cancer and placenta development

por Costanzo, Vincenzo, Bardelli, Alberto, Siena, Salvatore, Abrignani, Sergio
Publicado 2018

Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases

por Andreano, Anita, Valsecchi, Maria Grazia, Russo, Antonio Giampiero, Siena, Salvatore
Publicado 2021

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

por Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Balfour, Julia, Bardelli, Alberto
Publicado 2009

An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory...

por Poulin-Costello, Melanie, Azoulay, Laurent, Van Cutsem, Eric, Peeters, Marc, Siena, Salvatore, Wolf, Michael
Publicado 2013

Early‐onset colorectal cancer in young individuals

por Mauri, Gianluca, Sartore‐Bianchi, Andrea, Russo, Antonio‐Giampiero, Marsoni, Silvia, Bardelli, Alberto, Siena, Salvatore
Publicado 2018

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

por Amodio, Vito, Mauri, Gianluca, Reilly, Nicole M., Sartore-Bianchi, Andrea, Siena, Salvatore, Bardelli, Alberto, Germano, Giovanni
Publicado 2021

Liquid biopsies to monitor and direct cancer treatment in colorectal cancer

por Mauri, Gianluca, Vitiello, Pietro Paolo, Sogari, Alberto, Crisafulli, Giovanni, Sartore-Bianchi, Andrea, Marsoni, Silvia, Siena, Salvatore, Bardelli, Alberto
Publicado 2022

The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review

por Lombardo, Roberta, Tosi, Federica, Nocerino, Annunziata, Bencardino, Katia, Gambi, Valentina, Ricotta, Riccardo, Spina, Francesco, Siena, Salvatore, Sartore-Bianchi, Andrea
Publicado 2020

Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

por Gandhi, Anita K., Shi, Tao, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Tabernero, Josep, Siena, Salvatore, Schafer, Peter H., Chopra, Rajesh
Publicado 2013

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

por Goldberg, Richard M, Montagut, Clara, Wainberg, Zev A, Ronga, Philippe, Audhuy, François, Taieb, Julien, Stintzing, Sebastian, Siena, Salvatore, Santini, Daniele
Publicado 2018

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions

por Roncato, Rossana, Angelini, Jacopo, Pani, Arianna, Cecchin, Erika, Sartore-Bianchi, Andrea, Siena, Salvatore, De Mattia, Elena, Scaglione, Francesco, Toffoli, Giuseppe
Publicado 2020

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

por Sartore-Bianchi, Andrea, Valtorta, Emanuele, Amatu, Alessio, Veronese, Silvio, Lauricella, Calogero, Bonazzina, Erica, Siravegna, Giulia, Truini, Mauro, Bardelli, Alberto, Siena, Salvatore
Publicado 2016

Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving...

por Taieb, Julien, Rivera, Fernando, Siena, Salvatore, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Gallego, Javier, Geissler, Michael, Koukakis, Reija, Demonty, Gaston, Peeters, Marc
Publicado 2017

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first...

por Peeters, Marc, Price, Timothy, Taieb, Julien, Geissler, Michael, Rivera, Fernando, Canon, Jean-Luc, Pentheroudakis, George, Koukakis, Reija, Burdon, Peter, Siena, Salvatore
Publicado 2018

KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment

por Normanno, Nicola, Pinto, Carmine, Castiglione, Francesca, Bardelli, Alberto, Gambacorta, Marcello, Botti, Gerardo, Nappi, Oscar, Siena, Salvatore, Ciardiello, Fortunato, Taddei, GianLuigi, Marchetti, Antonio
Publicado 2011

Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

por Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Publicado 2016

Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity

por Pizzutilo, Elio Gregory, Romanò, Rebecca, Roazzi, Laura, Agostara, Alberto G., Oresti, Sara, Zeppellini, Annalisa, Giannetta, Laura, Cerea, Giulio, Signorelli, Diego, Siena, Salvatore, Sartore-Bianchi, Andrea
Publicado 2023